Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory mult...

ανά Hájek, Roman, Bryce, Richard, Ro, Sunhee, Klencke, Barbara, Ludwig, Heinz
Έκδοση 2012

Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study

ανά Yung, W.K. Alfred, Vredenburgh, James J., Cloughesy, Timothy F., Nghiemphu, Phioanh, Klencke, Barbara, Gilbert, Mark R., Reardon, David A., Prados, Michael D.
Έκδοση 2010

Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials

ανά Van Heertum, Ronald L, Scarimbolo, Robert, Wolodzko, John G, Klencke, Barbara, Messmann, Richard, Tunc, Feza, Sokol, Levi, Agarwal, Rajan, Strafaci, James A, O’Neal, Michael
Τόπος έκδοσης Drug Des Devel Ther (2017)